Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Aralez Pharma, Anchored In Cardiovascular, Will Be Prowling For Assets

This article was originally published in The Pink Sheet Daily

Executive Summary

The new company, to be formed through the merger of Pozen and Tribute, will develop a commercial organization to sell Yosprala and look to bring in new assets through licensing and M&A.

Advertisement

Related Content

Approval Might Be The Least Of Aralez's Challenges With Yosprala

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register